Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2009;119:1311-1319
doi: 10.1161/CIRCULATIONAHA.108.831453
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Srinivasan, M.
Right arrow Articles by Prasad, A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Srinivasan, M.
Right arrow Articles by Prasad, A.
Related Collections
Right arrow Catheter-based coronary interventions: stents
Right arrow Other Treatment
Right arrow Acute coronary syndromes
Right arrow Acute myocardial infarction

(Circulation. 2009;119:1311-1319.)
© 2009 American Heart Association, Inc.


New Drugs and Technologies

Adjunctive Thrombectomy and Distal Protection in Primary Percutaneous Coronary Intervention

Impact on Microvascular Perfusion and Outcomes

Manivannan Srinivasan, MBBS, MRCP; Charanjit Rihal, MD; David R. Holmes, MD; Abhiram Prasad, MD, FRCP, FESC

From the Division of Cardiovascular Diseases and Department of Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minn.

Correspondence to Abhiram Prasad, MD, Mayo Clinic, 200 First St SW, Rochester, MN 55905. E-mail prasad.abhiram{at}mayo.edu

A significant proportion of patients with ST-elevation myocardial infarction have persistent impairment of microvascular blood flow despite successful reperfusion of epicardial vessels. Microvascular dysfunction has been associated with larger infarct size, increased predisposition to ventricular arrhythmias, heart failure, cardiogenic shock, recurrent myocardial infarction, and death. It remains unclear whether this association is of direct mechanistic significance or whether the microcirculatory injury is an epiphenomenon and a manifestation of greater ischemic insult to the myocardium. Although several potential mechanisms have been proposed for the microvascular dysfunction, distal microembolization during mechanical reperfusion is likely to be an important contributor. Consequently, there has been increasing interest in the concept of adjunctive mechanical thrombectomy to improve outcomes in primary percutaneous coronary intervention. Until recently, randomized trials of thrombectomy and distal protection devices during primary percutaneous coronary intervention have provided conflicting results with no definitive evidence for efficacy. The recently published Thrombus Aspiration During Percutaneous Coronary Intervention in Acute Myocardial Infarction Study has rekindled the interest in this area. This trial is the largest randomized study of a thrombectomy device published to date and demonstrates that adjunctive treatment with aspiration thrombectomy during primary percutaneous coronary intervention improves surrogate and clinical end points. The aim of the present report is to review the evidence to date on the role of mechanical thrombectomy and embolic protection in native coronary arteries during primary percutaneous coronary intervention.


Key Words: thrombus • percutaneous coronary intervention • thrombectomy • distal protection devices • myocardial infarction




This article has been cited by other articles:


Home page
J Am Coll Cardiol IntvHome page
A. Prasad
Post-Conditioning for Cardioprotection During Reperfusion Therapy: Too Good to Be True?
J. Am. Coll. Cardiol. Intv., January 1, 2010; 3(1): 56 - 57.
[Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
S. Jacquet, X. Yin, P. Sicard, J. Clark, G. S. Kanaganayagam, M. Mayr, and M. S. Marber
Identification of Cardiac Myosin-binding Protein C as a Candidate Biomarker of Myocardial Infarction by Proteomics Analysis
Mol. Cell. Proteomics, December 1, 2009; 8(12): 2687 - 2699.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Prasad, G. W. Stone, D. R. Holmes, and B. Gersh
Reperfusion Injury, Microvascular Dysfunction, and Cardioprotection: The "Dark Side" of Reperfusion
Circulation, November 24, 2009; 120(21): 2105 - 2112.
[Full Text] [PDF]


Home page
CirculationHome page
G. Heusch, P. Kleinbongard, D. Bose, B. Levkau, M. Haude, R. Schulz, and R. Erbel
Coronary Microembolization: From Bedside to Bench and Back to Bedside
Circulation, November 3, 2009; 120(18): 1822 - 1836.
[Abstract] [Full Text] [PDF]